These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6337412)

  • 1. A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats.
    Myburgh DP; Smith R; Diamond TH; Faitelson HL; Sommers DK
    S Afr Med J; 1983 Feb; 63(8):263-5. PubMed ID: 6337412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of sotalol in suppressing ventricular ectopic beats.
    Myburgh DP; Goldman aP; Cartoon J; Schamroth JM
    S Afr Med J; 1979 Aug; 56(8):295-8. PubMed ID: 399099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
    Kubac G; Klinke WP; Grace M
    Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
    Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
    Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.
    Nademanee K; Schleman MM; Singh BN; Morganroth J; Reid PR; Stritar JA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1109-15. PubMed ID: 6207720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of low-dose nadolol for ventricular arrhythmias.
    Morganroth J; Duchin KL
    Am J Cardiol; 1986 Aug; 58(3):273-8. PubMed ID: 3739916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
    Cobbe SM; Alexopoulos D; Winner SJ; McCaie CP; Cobbe PC; Johnston J
    Eur Heart J; 1988 Jan; 9(1):24-31. PubMed ID: 2450026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sotalol: a breakthrough antiarrhythmic?
    Nappi JM; McCollam PL
    Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Sotalol: death by the SWORD or deserving of further consideration for clinical use?
    Doggrell SA; Brown L
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1625-34. PubMed ID: 11060766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
    Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
    J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic drug effectiveness. Proposal for a new approach based on pharmacological hourly effects].
    Maia IG; Seixas TN; Costa AM; Perez AK; Alves PA
    Arq Bras Cardiol; 1995 Jun; 64(6):525-31. PubMed ID: 8561671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effects of sotalol and atenolol given once daily.
    Leary WP; Asmal AC; Brayshaw P; Williams P
    S Afr Med J; 1980 Apr; 57(17):692-5. PubMed ID: 6996120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of sotalol in idiopathic ventricular arrhythmia originating in the right ventricular outflow tract].
    Maia IG; Seixas TN; Costa AM; Peres AK; Magalhães Júnior A; Sá R; Alves PA
    Arq Bras Cardiol; 1994 Jul; 63(1):59-63. PubMed ID: 7857216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias].
    Luczak D; Dabrowski R; Szwed H; Gasior Z; Stanke A; Jasek S; Skrabucha B; Matar A; Kowalik I
    Pol Merkur Lekarski; 1997 Feb; 2(8):122-5. PubMed ID: 9538657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sotalol: a new class III antiarrhythmic agent.
    Zanetti LA
    Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.